A detailed history of Qube Research & Technologies LTD transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 87,139 shares of LNTH stock, worth $7.78 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
87,139
Previous 145,295 40.03%
Holding current value
$7.78 Million
Previous $11.7 Million 18.02%
% of portfolio
0.01%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$77.7 - $123.62 $4.52 Million - $7.19 Million
-58,156 Reduced 40.03%
87,139 $9.56 Million
Q2 2024

Aug 14, 2024

SELL
$58.87 - $83.05 $7.91 Million - $11.2 Million
-134,291 Reduced 48.03%
145,295 $11.7 Million
Q1 2024

May 14, 2024

BUY
$51.07 - $68.26 $14.1 Million - $18.9 Million
276,881 Added 10235.9%
279,586 $17.4 Million
Q4 2023

Feb 13, 2024

BUY
$55.6 - $77.89 $150,398 - $210,692
2,705 New
2,705 $167,000
Q2 2023

Aug 14, 2023

BUY
$82.41 - $99.65 $2.66 Million - $3.22 Million
32,338 New
32,338 $2.71 Million
Q4 2022

Feb 14, 2023

BUY
$48.76 - $77.67 $2.81 Million - $4.48 Million
57,729 Added 271.47%
78,994 $4.03 Million
Q3 2022

Nov 14, 2022

BUY
$61.42 - $86.29 $1.31 Million - $1.83 Million
21,265 New
21,265 $1.5 Million
Q1 2022

May 09, 2022

SELL
$24.28 - $56.64 $279,511 - $652,039
-11,512 Closed
0 $0
Q4 2021

Feb 01, 2022

BUY
$22.54 - $30.44 $259,480 - $350,425
11,512 New
11,512 $333,000
Q1 2021

May 14, 2021

SELL
$13.77 - $21.66 $171,326 - $269,493
-12,442 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$10.75 - $14.91 $133,751 - $185,510
12,442 New
12,442 $168,000
Q2 2020

Aug 14, 2020

SELL
$10.34 - $15.51 $104,351 - $156,526
-10,092 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$9.11 - $20.05 $91,938 - $202,344
10,092 New
10,092 $129,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.14B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.